End-Stage Renal Disease (ESRD) Drugs Report

By www.reliablemarketinsights.com

Report Details

Report Name

Global End-Stage Renal Disease (ESRD) Drugs Market Research Report 2023 Story

Pages

94

Price

$ 2900

Features

End-Stage Renal Disease (ESRD) Drugs Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              CTI BioPharma Corp
Merck & Co Inc
Novartis AG
Prolong Pharmaceuticals LLC
VESSL Therapeutics Ltd